Literature DB >> 15246183

The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database.

William L Read1, Nathan C Page, Ryan M Tierney, Jay F Piccirillo, Ramaswamy Govindan.   

Abstract

Bronchioloalveolar carcinoma of the lung (BAC) is a subtype of adenocarcinoma of the lung. Although traditionally grouped with other non-small cell lung carcinomas (NSCLC), BAC has unique morphological features and clinical behavior such as bilateral lung involvement, indolent course and lack of association with smoking. Some epidemiologic studies report a significant increase in the incidence of BAC. We used the SEER database to compare the incidence, demographics, and overall survival of BAC patients as compared to other NSCLC types over the past two decades (1979-1998). Although the incidence of BAC has increased over the past two decades, BAC represents less than 4% of all NSCLC in every time period evaluated. The 1 year survival rate is significantly better for BAC patients relative to other histological subtypes of NSCLC. There has not been a marked increase in the incidence of BAC reported to SEER over the past 20 years.

Entities:  

Mesh:

Year:  2004        PMID: 15246183     DOI: 10.1016/j.lungcan.2004.01.019

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  26 in total

1.  Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.

Authors:  Robert A Meguid; Craig M Hooker; James Harris; Li Xu; William H Westra; J Timothy Sherwood; Marc Sussman; Stephen M Cattaneo; James Shin; Solange Cox; Joani Christensen; Yelena Prints; Nance Yuan; Jennifer Zhang; Stephen C Yang; Malcolm V Brock
Journal:  Chest       Date:  2010-05-27       Impact factor: 9.410

2.  The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Authors:  Morgan L Cox; Chi-Fu Jeffrey Yang; Paul J Speicher; Kevin L Anderson; Zachary W Fitch; Lin Gu; Robert Patrick Davis; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; David H Harpole; Mark F Berry
Journal:  J Thorac Oncol       Date:  2017-01-08       Impact factor: 15.609

3.  Cetuximab for the treatment of advanced bronchioloalveolar carcinoma (BAC): an Eastern Cooperative Oncology Group phase II study (ECOG 1504).

Authors:  Suresh S Ramalingam; Ju-Whei Lee; Chandra P Belani; Seena C Aisner; Jill Kolesar; Craig Howe; Mario R Velasco; Joan H Schiller
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

4.  Knockdown of FOXP1 promotes the development of lung adenocarcinoma.

Authors:  Hua Sheng; Xiangyang Li; Yi Xu
Journal:  Cancer Biol Ther       Date:  2018-11-08       Impact factor: 4.742

5.  Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions.

Authors:  Jon O Ebbert; Laveena Chhatwani; Marie Christine Aubry; Jason Wampfler; Shawn Stoddard; Fang Zhang; Guibin Qiao; Mariza de Andrade; Ping Yang
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

6.  Image Diagnosis: Bronchioloalveolar Carcinoma Presenting as Unilateral "Crazy-Paving" Pattern on High-Resolution Computed Tomography.

Authors:  Vikas Pilaniya; Shekhar Kunal; Sudhir Jain; Ashok Shah
Journal:  Perm J       Date:  2016-03-21

7.  Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies.

Authors:  Beate Pesch; Benjamin Kendzia; Per Gustavsson; Karl-Heinz Jöckel; Georg Johnen; Hermann Pohlabeln; Ann Olsson; Wolfgang Ahrens; Isabelle Mercedes Gross; Irene Brüske; Heinz-Erich Wichmann; Franco Merletti; Lorenzo Richiardi; Lorenzo Simonato; Cristina Fortes; Jack Siemiatycki; Marie-Elise Parent; Dario Consonni; Maria Teresa Landi; Neil Caporaso; David Zaridze; Adrian Cassidy; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Isabelle Stücker; Eleonora Fabianova; Rodica Stanescu Dumitru; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Charles M Rudin; Paul Brennan; Paolo Boffetta; Kurt Straif; Thomas Brüning
Journal:  Int J Cancer       Date:  2011-12-14       Impact factor: 7.396

8.  Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).

Authors:  Suresh S Ramalingam; Angela M Davies; Jeffrey Longmate; Martin J Edelman; Primo N Lara; Everett E Vokes; Miguel Villalona-Calero; Barbara Gitlitz; Karen Reckamp; Ravi Salgia; John J Wright; Chandra P Belani; David R Gandara
Journal:  J Thorac Oncol       Date:  2011-10       Impact factor: 15.609

9.  Epidemiology of non-small cell lung cancer in Asian Americans: incidence patterns among six subgroups by nativity.

Authors:  Dan J Raz; Scarlett L Gomez; Ellen T Chang; Jae Y Kim; Theresa H M Keegan; Jane Pham; Jasleen Kukreja; Robert A Hiatt; David M Jablons
Journal:  J Thorac Oncol       Date:  2008-12       Impact factor: 15.609

10.  HMGA2 participates in transformation in human lung cancer.

Authors:  Francescopaolo Di Cello; Joelle Hillion; Alexandra Hristov; Lisa J Wood; Mita Mukherjee; Andrew Schuldenfrei; Jeanne Kowalski; Raka Bhattacharya; Raheela Ashfaq; Linda M S Resar
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.